Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Satavaptan> ?p ?o. }
Showing items 1 to 47 of
47
with 100 items per page.
- Satavaptan abstract "Satavaptan (INN; codenamed SR121463, planned tradename Aquilda) is a vasopressin-2 receptor antagonist undergoing research for the treatment of hyponatremia. It is also being studied for the treatment of ascites.It was developed by Sanofi-Aventis. As of 2008, it is under regulatory review in the European Union.".
- Satavaptan atcPrefix "none".
- Satavaptan casNumber "185913-78-4".
- Satavaptan fdaUniiCode "AJS8S3P31H".
- Satavaptan iupacName "N-(tert-butyl)-4-{[(1s,4s)-5'-ethoxy-4-(2-morpholin-4-ylethoxy)-2'-oxospiro[cyclohexane-1,3'-indol]-1'(2'H)-yl]sulfonyl}-3-methoxybenzamide".
- Satavaptan pubchem "9810773".
- Satavaptan thumbnail Satavaptan_structure.svg?width=300.
- Satavaptan wikiPageID "18065584".
- Satavaptan wikiPageRevisionID "593003483".
- Satavaptan atcPrefix "none".
- Satavaptan c "33".
- Satavaptan casNumber "185913".
- Satavaptan h "45".
- Satavaptan hasPhotoCollection Satavaptan.
- Satavaptan iupacName "N--4-{[-5'-ethoxy-4--2'-oxospiro[cyclohexane-1,3'-indol]-1'-yl]sulfonyl}-3-methoxybenzamide".
- Satavaptan molecularWeight "643.789".
- Satavaptan n "3".
- Satavaptan o "8".
- Satavaptan pubchem "9810773".
- Satavaptan s "1".
- Satavaptan unii "AJS8S3P31H".
- Satavaptan verifiedrevid "443306451".
- Satavaptan width "280".
- Satavaptan subject Category:Diuretics.
- Satavaptan subject Category:Hormonal_agents.
- Satavaptan type Agent109190918.
- Satavaptan type Agent114778436.
- Satavaptan type CausalAgent100007347.
- Satavaptan type DiureticDrug103214670.
- Satavaptan type Diuretics.
- Satavaptan type Drug103247620.
- Satavaptan type HormonalAgents.
- Satavaptan type Matter100020827.
- Satavaptan type PhysicalEntity100001930.
- Satavaptan type Substance100020090.
- Satavaptan type Drug.
- Satavaptan type DrugProduct.
- Satavaptan type FunctionalSubstance.
- Satavaptan comment "Satavaptan (INN; codenamed SR121463, planned tradename Aquilda) is a vasopressin-2 receptor antagonist undergoing research for the treatment of hyponatremia. It is also being studied for the treatment of ascites.It was developed by Sanofi-Aventis. As of 2008, it is under regulatory review in the European Union.".
- Satavaptan label "Satavaptan".
- Satavaptan sameAs m.047mr0k.
- Satavaptan sameAs Q7425965.
- Satavaptan sameAs Q7425965.
- Satavaptan sameAs Satavaptan.
- Satavaptan wasDerivedFrom Satavaptan?oldid=593003483.
- Satavaptan depiction Satavaptan_structure.svg.
- Satavaptan isPrimaryTopicOf Satavaptan.
